These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10493845)

  • 1. Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme.
    Hofman-Bang C; Lisspers J; Nordlander R; Nygren A; Sundin O; Ohman A; Rydén L
    Eur Heart J; 1999 Oct; 20(20):1465-74. PubMed ID: 10493845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Follow-up study of programmed intervention of hyperuricemia in the prevention and treatment of cardiovascular morbid change].
    Zhu WH; Fang LZ; Chen LY; Chen ZW; Dai HL; Chen JH
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):662-6. PubMed ID: 20450723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of lifestyle behavior change in coronary artery disease: effects on recurrent coronary events after percutaneous coronary intervention.
    Lisspers J; Sundin O; Ohman A; Hofman-Bang C; Rydén L; Nygren A
    Health Psychol; 2005 Jan; 24(1):41-8. PubMed ID: 15631561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an expanded cardiac rehabilitation programme in patients treated for an acute myocardial infarction or a coronary artery by-pass graft operation.
    Plüss CE; Karlsson MR; Wallen N; Billing E; Held C
    Clin Rehabil; 2008 Apr; 22(4):306-18. PubMed ID: 18390974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of cardiovascular risk factors in patients after coronary artery bypass grafting with an in-hospital rehabilitation programme (WHO Stage I of Rehabilitation): 1-year follow-up].
    Schimmer C; Krannich JH; Brauchle-Hopp U; Elert O
    Rehabilitation (Stuttg); 2006 Apr; 45(2):95-101. PubMed ID: 16575715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health related quality of life after percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with acute coronary syndromes without ST-segment elevation. 12-month follow up.
    Szygula-Jurkiewicz B; Zembala M; Wilczek K; Wojnicz R; Polonski L
    Eur J Cardiothorac Surg; 2005 May; 27(5):882-6. PubMed ID: 15848330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in cardiac rehabilitation.
    O'Farrell P; Murray J; Huston P; LeGrand C; Adamo K
    Can J Cardiol; 2000 Mar; 16(3):319-25. PubMed ID: 10744794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The short- and long-term motivational effects of a patient education programme for patients with coronary artery bypass grafting].
    Krannich JH; Weyers P; Lueger S; Faller H; Schimmer C; Deeg P; Elert O; Leyh R
    Rehabilitation (Stuttg); 2008 Aug; 47(4):219-25. PubMed ID: 18704871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of physical training after myocardial infarction and its effect on return to work, morbidity and mortality.
    Palatsi I
    Acta Med Scand Suppl; 1976; 599():7-84. PubMed ID: 16981325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase III rehabilitation after heart transplantation].
    Tegtbur U; Busse MW; Jung K; Markofsky A; Machold H; Brinkmeier U; Künsebeck HW; Haverich A; Pethig K
    Z Kardiol; 2003 Nov; 92(11):908-15. PubMed ID: 14634760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in cardiovascular disease risk factors: 6-month results from Project Active.
    Dunn AL; Marcus BH; Kampert JB; Garcia ME; Kohl HW; Blair SN
    Prev Med; 1997; 26(6):883-92. PubMed ID: 9388801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular risk reduction: impact of an international project].
    Colle B; Brusaferro S;
    Ann Ig; 2008; 20(3 Suppl 1):43-8. PubMed ID: 18773604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How important are individual counselling, expectancy beliefs and autonomy for the maintenance of exercise after cardiac rehabilitation?
    Mildestvedt T; Meland E; Eide GE
    Scand J Public Health; 2008 Nov; 36(8):832-40. PubMed ID: 18684777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong.
    Lee VW; Fan CS; Li AW; Chau AC
    J Clin Pharm Ther; 2009 Aug; 34(4):407-14. PubMed ID: 19583673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
    Olsen MH; Wachtell K; Beevers G; Dahlöf B; de Simone G; Devereux RB; de Faire U; Fyhrquist F; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Lyle PA; Nieminen MS; Omvik P; Oparil S; Wedel H
    J Hypertens; 2009 Mar; 27(3):567-74. PubMed ID: 19262226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for coronary heart disease in two similar Indian population groups, one residing in India, and the other in Sydney, Australia.
    Mahajan D; Bermingham MA
    Eur J Clin Nutr; 2004 May; 58(5):751-60. PubMed ID: 15116078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.